Taurine and skeletal muscle disorders

被引:59
|
作者
Camerino, DC
Tricarico, D
Pierno, S
Desaphy, JF
Liantonio, A
Pusch, M
Burdi, R
Camerino, C
Fraysse, B
De Luca, A
机构
[1] Univ Bari, Dipartimento Farmacobiol, Sez Farmacol, Pharmacol Unit, I-70125 Bari, Italy
[2] CNR, Inst Biophys, Genoa, Italy
[3] Univ Bari, Dept Human Anat & Histol, Bari, Italy
关键词
taurine; skeletal muscle; inherited and acquired myopathies; therapeutic potential;
D O I
10.1023/B:NERE.0000010442.89826.9c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Taurine is abundantly present in skeletal muscle. We give evidence that this amino acid exerts both short-term and long-term actions in the control of ion channel function and calcium homeostasis in striated fibers. Short-term actions can be estimated as the ability of this amino acid to acutely modulate both ion channel gating and the function of the structures involved in calcium handling. Long-term effects can be disclosed in situations of tissue taurine depletion and are likely related to the ability of the intracellular taurine to control transducing pathways as well as homeostatic and osmotic equilibrium in the tissue. The two activities are strictly linked because the intracellular level of taurine modulates the sensitivity of skeletal muscle to the exogenous application of taurine. Myopathies in which ion channels are directly or indirectly involved, as well as inherited or acquired pathologies characterized by metabolic alterations and change in calcium homeostasis, are often correlated with change in muscle taurine concentration and consequently with an enhanced therapeutic activity of this amino acid. We discuss both in vivo and in vitro evidence that taurine, through its ability to control sarcolemmal excitability and muscle contractility, can prove beneficial effects in many muscle dysfunctions.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 50 条
  • [21] Skeletal muscle disorders of glycogenolysis and glycolysis
    Godfrey, Richard
    Quinlivan, Ros
    [J]. NATURE REVIEWS NEUROLOGY, 2016, 12 (07) : 393 - 402
  • [22] Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised
    Warskulat, U
    Flögel, U
    Jacoby, C
    Hartwig, HG
    Thewissen, M
    Merx, MW
    Molojavyi, A
    Heller-Stilb, B
    Schrader, J
    Häussinger, D
    [J]. FASEB JOURNAL, 2004, 18 (01): : 577 - +
  • [23] Disorders of lipid metabolism in skeletal muscle
    Cwik, VA
    [J]. NEUROLOGIC CLINICS, 2000, 18 (01) : 167 - +
  • [24] Carbohydrate oxidation disorders of skeletal muscle
    Vorgerd, M
    Zange, J
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (06): : 611 - 617
  • [25] Skeletal muscle disorders in heart failure
    Lunde, PK
    Sjaastad, I
    Thorud, HMS
    Sejersted, OM
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 2001, 171 (03): : 277 - 294
  • [26] THE ENZYMOLOGY OF SKELETAL-MUSCLE DISORDERS
    LOTT, JA
    LANDESMAN, PW
    [J]. CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1984, 20 (02): : 153 - 190
  • [27] Skeletal muscle disorders of glycogenolysis and glycolysis
    Richard Godfrey
    Ros Quinlivan
    [J]. Nature Reviews Neurology, 2016, 12 : 393 - 402
  • [28] Pathology of skeletal muscle in mitochondrial disorders
    Bourgeois, JM
    Tarnopolsky, MA
    [J]. MITOCHONDRION, 2004, 4 (5-6) : 441 - 452
  • [29] The Genetics of Skeletal Muscle Disorders in Horses
    Mickelson, James R.
    Valberg, Stephanie J.
    [J]. ANNUAL REVIEW OF ANIMAL BIOSCIENCES, VOL 3, 2015, 3 : 197 - 217
  • [30] TREATMENT OF PAINFUL DISORDERS OF SKELETAL MUSCLE
    MODELL, W
    TRAVELL, J
    [J]. NEW YORK STATE JOURNAL OF MEDICINE, 1948, 48 (18) : 2050 - 2059